The overexpression of SOX9 has also been detected in the lymph nodes of prostate cancer xenografts, in which SOX9 was found to enhance cellular growth, angiogenesis and invasion by promoting epithelial cells to expand into mesenchyme cells during fetal prostate development [7]. Here, SOX9 is linked to prostate carcinoma.